Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Health-tech adopter of a Strategy-style BTC treasury. Small operating business overshadowed by the BTC HODL line on the balance sheet.
| Announcement Date | BTC Purchased | USD Price/BTC | Running Total BTC | Notes | |
|---|---|---|---|---|---|
| First purchase | May 28, 2024 | 581 | ~$69,000 | 581 | Pivot to BTC treasury announced; first SMLR BTC purchase |
| Subsequent 2024-H2 tranches | Jun-Dec 2024 (multiple) | ~600 cumulative | ~$70,000-75,000 weighted | ~1,180 | Multiple monthly tranches |
| 2024-Q4 acceleration | Oct-Dec 2024 | ~620 cumulative | ~$85,000 weighted | ~1,800 | Convertible-debt-funded acceleration |
| 2025-Q1 | Jan-Mar 2025 | ~580 | ~$82,500 weighted | ~2,380 | Continued accumulation |
| 2025-Q2 | Apr-Jun 2025 | ~720 | ~$98,000 weighted | ~3,100 | Above-spot accumulation |
| 2025-Q3 (Strive merger close) | Jul-Sep 2025 | ~620 | ~$80,500 weighted | ~3,720 | Combined STRV entity |
| 2025-Q4 | Oct-Dec 2025 | ~510 | ~$92,000 weighted | ~4,230 | Continued strategy |
| 2026-Q1 | Jan-Mar 2026 | ~270 | ~$83,000 weighted | ~4,500 | Slowed pace amid BTC consolidation |
| Editorial. Why this matters | Strategic context | SMLR/STRV is structurally smaller than MSTR + Metaplanet but represents the marquee 'mid-cap operating business + BTC treasury' template. The healthcare-tech operating business (Quantiflo blood-vessel-imaging; ~$30M/yr revenue) is structurally small relative to BTC NAV (~$1B+). Marquee question: does SMLR/STRV cross 10,000 BTC by FY2027, validating the mid-cap BTC-treasury model? |
FY 2022 (pre-BTC)-FY 2027 target
2014-2024

$SMLR
Health-tech adopter of a Strategy-style BTC treasury. Small operating business overshadowed by the BTC HODL line on the balance sheet.